Lipids represent a valuable target for metabolomic studies since altered lipid metabolism is
known to drive the pathological changes in cardiovascular disease (CVD). Metabolomic …

Metabolic syndrome (MetS) has a worldwide tendency to increase and depends on many
components, which explains the complexity of diagnosis, approaches to the prevention, and …

BACKGROUND AND AIMS: Obesity, an independent risk factor for cardiovascular disease
(CVD), has been associated with the early development of coronary atherosclerosis in …

Background Nonalcoholic fatty liver diseases are often associated with obesity, insulin
resistance, and excessive visceral fat accumulation. The aims of this study were (1) to …

Aims/hypothesis Types of dietary fat have been related to components of the metabolic
syndrome. Serum fatty acid composition mainly reflects dietary fat intake, but also …

Background: Together with adiposity, plasma fatty acid (FA) composition can modulate the
development of the metabolic syndrome (MS). Objective: Our aim was to investigate the …

Ceramides may mediate saturated fat–induced insulin resistance, but there are no data
comparing ceramide concentrations between human tissues. We therefore performed …

Aims/hypothesis The weak relationship between insulin resistance and total serum
triacylglycerols (TGs) could be in part due to heterogeneity of TG molecules and their …

The metabolic syndrome (MetS) produces low-grade inflammation, endothelial dysfunction,
platelet hyperactivity, oxidative stress and ultimately contributes to cardiovascular disease …

The MS (metabolic syndrome) is a cluster of clinical and biochemical abnormalities
characterized by central obesity, dyslipidaemia [hypertriglyceridaemia and decreased HDL …